Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Ballard

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
JMIR Formative Research|November 10, 2022
Mental Health Outcomes for Youths With Public Versus Private Health Insurance Attending a Telehealth Intensive Outpatient Program: Quality Improvement AnalysisKate Gliske, Katie R Berry, Jaime Ballard, et al.
JMIR Formative Research|September 7, 2023
Predicting Youth and Young Adult Treatment Engagement in a Transdiagnostic Remote Intensive Outpatient Program: Latent Profile AnalysisKate Gliske, Katie R Berry, Jaime Ballard, et al.
Academic Pediatrics|August 5, 2023
Multiple Perspectives on Motivating Parents in Pediatric Primary Care to Initiate Participation in Parenting ProgramsChristopher J Mehus, Gretchen Buchanan, Jaime Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic designMichael B Harbut, Bhumit A Patel, Bryan K S Yeung, et al.
Plos Pathogens|July 18, 2015
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas DiseaseShilpi Khare, Steven L Roach, S Whitney Barnes, et al.
Nature|August 9, 2016
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessShilpi Khare, Advait S Nagle, Agnes Biggart, et al.
Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
JMIR Formative Research|November 10, 2022
Mental Health Outcomes for Youths With Public Versus Private Health Insurance Attending a Telehealth Intensive Outpatient Program: Quality Improvement AnalysisKate Gliske, Katie R Berry, Jaime Ballard, et al.
JMIR Formative Research|September 7, 2023
Predicting Youth and Young Adult Treatment Engagement in a Transdiagnostic Remote Intensive Outpatient Program: Latent Profile AnalysisKate Gliske, Katie R Berry, Jaime Ballard, et al.
Academic Pediatrics|August 5, 2023
Multiple Perspectives on Motivating Parents in Pediatric Primary Care to Initiate Participation in Parenting ProgramsChristopher J Mehus, Gretchen Buchanan, Jaime Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic designMichael B Harbut, Bhumit A Patel, Bryan K S Yeung, et al.
Plos Pathogens|July 18, 2015
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas DiseaseShilpi Khare, Steven L Roach, S Whitney Barnes, et al.
Nature|August 9, 2016
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessShilpi Khare, Advait S Nagle, Agnes Biggart, et al.
Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.
Pageof 2